Ardelyx, Inc. (ARDX)
5.92
-0.82
(-12.17%)
USD |
NASDAQ |
Feb 20, 12:11
Ardelyx EPS Diluted (Quarterly) : -0.004 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.805 |
| MannKind Corp. | 0.0256 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fate Therapeutics, Inc. | -0.271 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.969M |
| Revenue (Quarterly) | 110.33M |
| Total Expenses (Quarterly) | 111.30M |
| Enterprise Value | 1.603B |
| Gross Profit Margin (Quarterly) | 95.57% |
| Profit Margin (Quarterly) | -0.88% |
| Earnings Yield | -4.00% |
| Normalized Earnings Yield | -4.002 |